Study Found 59% of Patients Undergoing TIF Procedure Had Remission of Gastroesophageal Reflux Disease Symptoms after Six Months REDMOND, Washington; October 15, 2015 – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal...
New CPT Code for the TIF Procedure Becomes Effective January 1, 2016 REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy to treat Gastroesophageal Reflux Disease (GERD), announced today assignment of Category I Current...
Data shows positive results from 192 patients followed up to 12-months at multiple centers SAN MATEO, Calif. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced that Karim Trad, MD,...
Publication of New Category I CPT Code is an Important Step in Establishing Access to Minimally Invasive Technology for Patients with Reflux SAN MATEO, Calif.–EndoGastric Solutions (EGS), developer of an incisionless approach to treat Gastroesophageal Reflux Disease...
